Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLO-ASC-TI for Lateral Epicondylitis
NCT02131077Phase 2Completed
- Sponsor
- Anterogen Co., Ltd.
- Start
- Jan 2014
- Primary completion
- Oct 2014
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of allo-asc in Lateral Epicondylitis (LET), sponsored by Anterogen Co., Ltd.. Started Jan 2014; status: completed.
02
Drugs
allo-asc
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT02131077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02131077.